EMDF COLUMBUS, Ohio--(BUSINESS WIRE)--Nov. 17, 2004--E Med Future, Inc. (OTCBB:EMDF - News) is hosting a luncheon for dignitaries and Ambassadors from more than 20 African nations for a formal introduction of NeedleZap®, a device that disintegrates used injection needles at their point of use. The event will take place at the University Club of Washington this Friday, November 19, 2004, from Noon until 2:00 p.m.
Dr. Lamine Ba, Ambassador of Senegal, who recently learned about NeedleZap® and has already endorsed the product to the Senegalese Ministry of Health, was integral in the organization of the meeting. According to the most recent report from the United Nations, an estimated 25 million people are infected with HIV in Sub-Saharan Africa. Senegal, in contrast, has done well in its fight to limit the spread of HIV/AIDS. The country has an infection rate of approximately 2 percent, one of the lowest on the African continent. For that reason, Dr. Ba felt strongly that other members of the African diplomatic community should learn about NeedleZap®.
"To be effective against curtailing the spread of HIV/AIDS, you have to look at all the root causes," said Dr. Ba, E Med's Guest of Honor at the event. "The re-use of contaminated needles is just one of many problems African countries have to combat if progress is to be made against this deadly disease. That's why it's important to hold this forum where the benefits of NeedleZap® can be explained and demonstrated."
